![David Renas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Renas
No más puestos en curso
Perfil
David Renas served as the Chief Financial Officer & General Counsel at Sangart, Inc. from 2002 to 2014.
He also worked as the Chief Financial Officer at Petra Pharma Corp.
from 2017 to 2020 and as the Chief Financial Officer at ObsEva SA in 2021.
Prior to these roles, he was a Principal at Deloitte & Touche.
Renas received his undergraduate degree from Stanford University and his graduate degree from the University of California, Davis.
Antiguos cargos conocidos de David Renas.
Empresas | Cargo | Fin |
---|---|---|
OBSEVA SA | Director Financiero/CFO | 01/01/2022 |
Petra Pharma Corp.
![]() Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Director Financiero/CFO | 01/01/2020 |
Sangart, Inc.
![]() Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | Director Financiero/CFO | 01/01/2014 |
Deloitte & Touche
![]() Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche provides audit, enterprise risk management, and financial advisory services. The company delivers services in four professional areas: audit, tax, consulting, and financial advisory services. It provides its clients with global services such as entering foreign markets, raising funds, and investing in Mainland China. The company was founded in June, 2003 and is headquartered in Taipei, Taiwan. | Corporate Officer/Principal | - |
Formación de David Renas.
University of California, Davis | Graduate Degree |
Stanford University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
OBSEVA SA | Health Technology |
Empresas privadas | 3 |
---|---|
Sangart, Inc.
![]() Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | Health Technology |
Deloitte & Touche
![]() Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche provides audit, enterprise risk management, and financial advisory services. The company delivers services in four professional areas: audit, tax, consulting, and financial advisory services. It provides its clients with global services such as entering foreign markets, raising funds, and investing in Mainland China. The company was founded in June, 2003 and is headquartered in Taipei, Taiwan. | Commercial Services |
Petra Pharma Corp.
![]() Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- David Renas